The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Specially Adapted Housing Assistive Technology Grant |
64.051 |
VA-SAHAT-16-01 |
| Limited Competition - Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT2) |
93.310 |
RFA-RM-15-018 |
| Pre-application: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Comprehensive Functional Mapping of Neuroanatomy and Neurobiology of Organs (OT1) |
93.310 |
RFA-RM-15-003 |
| Precision Medicine Initiative Cohort Program Participant Technologies Center (U24) |
93.310 |
RFA-PM-16-003 |
| Precision Medicine Initiative Cohort Program Biobank (U24) |
93.310 |
RFA-PM-16-004 |
| Precision Medicine Initiative Cohort Program Healthcare Provider Organization Enrollment Centers (UG3/UH3) |
93.310 |
RFA-PM-16-002 |
| Precision Medicine Initiative Cohort Program Coordinating Center (U2C) |
93.310 |
RFA-PM-16-001 |
| Coastal and Estuarine Land Conservation Program - Fiscal Year 2016 Great Lakes Competition |
11.419 |
NOAA-NOS-OCM-2016-2004625 |
| Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among K-12 Students in the United States |
93.084 |
RFA-CK-16-005 |
| Enhanced Surveillance for New Vaccine Preventable Diseases |
93.185 |
RFA-IP-16-004 |
| Evaluating the Impact of Non-pharmaceutical Measures on the Incidence of Influenza-like Illness (ILI) among |
93.084 |
CDC-RFA-CK-16-005 |
| Enhanced Surveillance for New Vaccine Preventable Diseases |
93.185 |
CDC-RFA-IP-16-004 |
| NHLBI Progenitor Cell Translational Consortium Coordinating Center (U24) |
93.837, 93.838, 93.839 |
RFA-HL-16-022 |
| NHLBI Progenitor Cell Translational Consortium (U01) |
93.837, 93.838, 93.839 |
RFA-HL-16-021 |
| Breast Cancer and the Environment Communication Research Initiative (R03) |
93.113, 93.399 |
RFA-ES-15-015 |
| Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) |
93.847 |
PAR-16-034 |
| Breast Cancer and the Environment Communication Research Initiative (R21) |
93.113, 93.399 |
RFA-ES-15-017 |
| Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States |
93.185 |
RFA-IP-16-002 |
| Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) |
93.847 |
PAS-16-033 |
| Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21) |
93.865 |
PA-16-031 |
| Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01) |
93.865 |
PA-16-032 |
| Research on Technical Improvement of Personal Protective Equipment (PPE) to be used in Healthcare Settings for Infection Control, including Ebola and other Emerging Pathogens |
93.823 |
RFA-CK-16-006 |
| Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01) |
93.847 |
RFA-DK-16-016 |
| Applying Metabolomics to Drive Biomarker Discovery in Symptom Science (R21) |
93.213, 93.361 |
PA-16-029 |
| Proteogenomic Data Analysis Centers for Clinical Proteomic Tumor Analysis Consortium (U24) |
93.393, 93.394, 93.396 |
RFA-CA-15-023 |
| Proteome Characterization Centers for Clinical Proteomic Tumor Analysis Consortium (U24) |
93.393, 93.394, 93.396 |
RFA-CA-15-021 |
| Proteogenomic Translational Research for Clinical Proteomic Tumor Analysis Consortium (U01) |
93.393, 93.394, 93.396 |
RFA-CA-15-022 |
| Impact of Aging on Currently Employed Animal Models of Disease and Chronic Conditions: Demonstration Projects (UH2/UH3) |
93.113, 93.121, 93.853, 93.855, 93.856, 93.866 |
RFA-AG-16-020 |
| Self-Help Homeownership Opportunity Program (SHOP) |
14.247 |
FR-5900-N-19 |
| Juvenile Reentry Assistance Program (JRAP) |
14.897 |
FR-5900-N-09 |
| NCI Research Specialist Award (R50) |
93.393, 93.394, 93.395, 93.396, 93.397, 93.398, 93.399 |
PAR-16-025 |
| Innovative Questions in Symptom Science and Genomics (R01) |
93.361 |
PA-16-024 |
| Metabolomics Data Analysis (R03) |
93.310 |
RFA-RM-15-021 |
| Innovative Questions in Symptom Science and Genomics (R21) |
93.361 |
PA-16-023 |
| NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01) |
93.233, 93.837, 93.838, 93.839 |
PAR-16-021 |
| International Centers of Excellence for Malaria Research (U19) |
93.855, 93.856 |
RFA-AI-15-056 |
| Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01) |
93.853 |
PAR-16-020 |
| Assistance to High Energy Cost Rural Communities |
10.859 |
RD-RUS-HECG15 |
| De-foa-0001385: Solutions To Improve The Energy Efficiency Of U.s. Small And Medium Commercial Buildings |
81.086 |
DE-FOA-0001385 |
| Human Pancreas Procurement and Analysis Program (HPPAP) (UC4) |
93.847 |
RFA-DK-15-027 |
Search Results 9641-9680 of 18325
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 [Next] |
